Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.

Dring AM, Davies FE, Fenton JA, Roddam PL, Scott K, Gonzalez D, Rollinson S, Rawstron AC, Rees-Unwin KS, Li C, Munshi NC, Anderson KC, Morgan GJ.

Clin Cancer Res. 2004 Sep 1;10(17):5692-701.

2.

MMSET: role and therapeutic opportunities in multiple myeloma.

Xie Z, Chng WJ.

Biomed Res Int. 2014;2014:636514. doi: 10.1155/2014/636514. Epub 2014 Jul 1. Review.

3.
5.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

6.

Plasma cell myeloma.

Lin P.

Hematol Oncol Clin North Am. 2009 Aug;23(4):709-27. doi: 10.1016/j.hoc.2009.04.012. Review.

PMID:
19577166
7.

New insights into the pathophysiology of multiple myeloma.

Seidl S, Kaufmann H, Drach J.

Lancet Oncol. 2003 Sep;4(9):557-64. Review.

PMID:
12965277
8.

Genomic aberrations and immunohistochemical markers as prognostic indicators in multiple myeloma.

Yeung J, Chang H.

J Clin Pathol. 2008 Jul;61(7):832-6. Epub 2007 Dec 12. Review.

PMID:
18077770
9.
10.

Many multiple myelomas: making more of the molecular mayhem.

Chesi M, Bergsagel PL.

Hematology Am Soc Hematol Educ Program. 2011;2011:344-53. doi: 10.1182/asheducation-2011.1.344. Review.

Supplemental Content

Support Center